BACKGROUND AND PURPOSE:

• In low- and middle-income countries, breast cancer is often detected at advanced stages
• Clinical breast examination (CBE) may be a good screening method in this setting
• Mittra et al. (BMJ, 2021) examined the efficacy of screening by CBE in downstaging breast cancer at diagnosis and in reducing mortality

METHODS:

• Prospective, cluster randomized controlled trial
• Setting
  • 20 geographically distinct clusters located in Mumbai, India over 20 years (May 1998 to March 2019)
    • 10 clusters were designated as screening clusters, and 10 as controls
• Participants
  • Women aged 35 to 64
  • No history of breast cancer
• Interventions
  • Screening
    • 4 screening rounds of clinical breast examination (conducted by trained female primary health workers) and cancer awareness every two years
    • Followed by five rounds of active surveillance every two years
  • Control
    • One round of cancer awareness
    • Followed by eight rounds of active surveillance every two years
• Health workers who performed CBE
  • Passed 10th grade education
  • Training period of approximately 4 weeks
• Primary outcomes
  • Downstaging of breast cancer at diagnosis
  • Reduction in mortality from breast cancer

RESULTS:

• Screening arm: 75,360 women | Control arm: 76,178 women
• Breast cancer was detected at an earlier age in the screening group (P = 0.01)
  • Screening: mean age 55.18 years
  • Control: 56.50 years
• There was a significant reduction in the proportion of women with stage III or IV disease in the screening group (P = 0.001)
  • Screening: 37%
  • Control: 47%
• 15% reduction in breast cancer mortality was observed in the screening arm but was non-significant (P = 0.07)
  • Screening: 20.82 deaths/100,000 person years (95% CI, 18.25 to 23.97)
  • Control: 24.62 (95% CI, 21.71 to 28.04)
  • Rate ratio 0.85 (95% CI, 0.71 to 1.01)
• There was a reduction in breast cancer mortality in women aged ≥50 on post-hoc analysis (P = 0.02)
  • Screening: 24.62 deaths/100,000 person years (95% CI, 20.62 to 29.76)
  • Control: 34.68 (95% CI, 27.54 to 44.37)
  • Rate ratio 0.71 (95% CI, 0.54 to 0.94)
• There was no significant reduction in women <50 (P = 0.37)
• There was no difference in all cause mortality between groups (P = 0.49)
  • Rate ratio 0.95 (95% CI, 0.81 to 1.10)
  • Authors note that “because breast cancer deaths comprise less than 3% of all deaths in women in India, we did not expect a reduction in all cause mortality in our study”

CONCLUSION:

• Clinical breast examination led to a significant downstaging of breast cancer at diagnosis
• While a 15% reduction in overall breast cancer mortality was not significant, there was a significant 30% reduction in women over 50 years of age
• The authors conclude that clinical breast examination is a viable screening option for low- and middle-income countries

Learn More – Primary Sources:

Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai

Related ObG Topics:

High-Deductible Health Care Plans and Delayed Breast Cancer Treatment

How Do Health Outcomes in the Richest Counties in the US Compare to Those of Average Citizens in Other Developed Nations?

How Effective Is Mammography in Reducing the Number of Advanced Breast Cancer Diagnoses?